Average stock performance after each discretionary buy, measured at 1, 3 and 6 months. 6 buys in history.
Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Oric Pharmaceuticals, Inc. | 112,500 | reported | 02 Jan 2026 | tx 75+5,701,999−1,800,321 |
| 4D Molecular Therapeutics, Inc. | 22,500 | reported | 17 Jun 2025 | tx 8+117,500−10,000 |
| Turning Point Therapeutics, Inc. | 8,500 | reported | 15 Jun 2020 | tx 2+23,500 |
| Ignyta, Inc. | 0 | reported | 08 Feb 2018 | tx 18+397,272−395,772 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 02 Jan 2026 | GRANT_AWARD | Oric Pharmaceuticals, Inc. | 675,000 | 0.00 USD | deriv |
| 02 Jan 2026 | GRANT_AWARD | Oric Pharmaceuticals, Inc. | 112,500 | 0.00 USD | deriv |
| 16 Dec 2025 | SALE | Oric Pharmaceuticals, Inc. | 33,374 | 9.06 USD | |
| 15 Dec 2025 | EXERCISE | Oric Pharmaceuticals, Inc. | 83,666 | 0.00 USD | |
| 15 Dec 2025 | EXERCISE | Oric Pharmaceuticals, Inc. | 33,333 | 0.00 USD | deriv |
| 15 Dec 2025 | EXERCISE | Oric Pharmaceuticals, Inc. | 22,000 | 0.00 USD | deriv |
| 15 Dec 2025 | EXERCISE | Oric Pharmaceuticals, Inc. | 28,333 | 0.00 USD | deriv |
| 06 Oct 2025 | SALE | Oric Pharmaceuticals, Inc. | 37,461 | 12.32 USD | |
| 01 Oct 2025 | SALE | Oric Pharmaceuticals, Inc. | 53,001 | 12.05 USD | |
| 30 Sept 2025 | SALE | Oric Pharmaceuticals, Inc. | 34,538 | 12.01 USD | |
| 22 Sept 2025 | SALE | Oric Pharmaceuticals, Inc. | 125,000 | 10.80 USD | |
| 17 Jun 2025 | GRANT_AWARD | 4D Molecular Therapeutics, Inc. | 22,500 | 0.00 USD | deriv |
| 02 Jan 2025 | GRANT_AWARD | Oric Pharmaceuticals, Inc. | 100,000 | 0.00 USD | deriv |
| 02 Jan 2025 | GRANT_AWARD | Oric Pharmaceuticals, Inc. | 600,000 | 0.00 USD | deriv |
| 16 Dec 2024 | SALE | Oric Pharmaceuticals, Inc. | 24,660 | 8.28 USD | |
| 15 Dec 2024 | EXERCISE | Oric Pharmaceuticals, Inc. | 67,000 | 0.00 USD | |
| 15 Dec 2024 | EXERCISE | Oric Pharmaceuticals, Inc. | 16,667 | 0.00 USD | deriv |
| 15 Dec 2024 | EXERCISE | Oric Pharmaceuticals, Inc. | 28,333 | 0.00 USD | deriv |
| 15 Dec 2024 | EXERCISE | Oric Pharmaceuticals, Inc. | 22,000 | 0.00 USD | deriv |
| 21 May 2024 | GRANT_AWARD | 4D Molecular Therapeutics, Inc. | 22,500 | 0.00 USD | deriv |
| 06 Mar 2024 | SALE | Oric Pharmaceuticals, Inc. | 40,000 | 16.21 USD | |
| 07 Feb 2024 | SALE | Oric Pharmaceuticals, Inc. | 26,042 | 12.30 USD | |
| 06 Feb 2024 | SALE | Oric Pharmaceuticals, Inc. | 13,958 | 12.12 USD | |
| 02 Jan 2024 | GRANT_AWARD | Oric Pharmaceuticals, Inc. | 510,000 | 0.00 USD | deriv |
| 02 Jan 2024 | GRANT_AWARD | Oric Pharmaceuticals, Inc. | 85,000 | 0.00 USD | deriv |
1 purchase reported after at least 12 months of silence — most recent on 23 Mar 2022.